A statistical model that takes into account clinical and demographic factors could help guide decisions about treatment in ...

Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.